Security record · archived quarter
AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
11Tracked holders
—Δ holders
2.57MShares held
$51.15MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | — | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | — | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | — | — |
| Q2 2024 | 11 | — | 2.57M | $51.15M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.04M | — | $20.68M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.04M | — | $20.68M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 486.55K | — | $9.69M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 486.55K | — | $9.69M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 249.44K | — | $4.97M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 217.43K | — | $4.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 217.43K | — | $4.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 146.98K | — | $2.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 146.98K | — | $2.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 146.98K | — | $2.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 122.79K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 103.54K | — | $2.06M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 97.18K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 64.64K | — | $1.29M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 27.53K | — | $548,358 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 16.13K | — | $321,389 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 44.71M shares, $512.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API